PuSH - Publikationsserver des Helmholtz Zentrums München

Chillappagari, S.* ; Müller, C.* ; Mahavadi, P.* ; Guenther, A.* ; Nahrlich, L.* ; Rosenblum, J.* ; Rubin, B.K.* ; Henke, M.O.

A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation.

J. Cyst. Fibros. 15, 325-331 (2016)
Verlagsversion Forschungsdaten DOI
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: Neutrophil elastase (NE) rapidly degrades gel-forming airway mucins in cystic fibrosis (CF) sputum. We hypothesized that KRP-109, a small molecule NE inhibitor, would inhibit CF mucin degradation in vitro. METHODS: Sputa were collected from CF patients (n=5) chronically or intermittently infected with Pseudomonas aeruginosa (P.a.). Mucin degradation was analyzed using western blot. Protease inhibitor studies were performed using alpha1-proteinase inhibitor (A1-PI Prolastin®) and KRP-109. Elastase activity assays were performed using spectrophotometry. RESULTS: There were significant differences in the amount of active NE in different CF sputum samples. KRP-109 decreased the NE driven mucin degradation in vitro. Pseudomonas elastases appeared to blunt elastase inhibition by A1-PI or KRP-109. CONCLUSION: Inhibitors of neutrophil and Pseudomonas-derived elastases might rescue mucus clearance and reverse airway obstruction in CF.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cystic Fibrosis ; Mucin ; Protease And Anti-protease Balance ; Small Molecule Inhibitors; Lung-disease; Pseudomonas-aeruginosa; Alpha-1-proteinase Inhibitor; Iron Homeostasis; Proteases; Inflammation; Efficacy; Alpha(1)-antitrypsin; Safety; Antiproteases
ISSN (print) / ISBN 1569-1993
e-ISSN 1873-5010
Zeitschrift Journal of Cystic Fibrosis
Quellenangaben Band: 15, Heft: 3, Seiten: 325-331 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam
Begutachtungsstatus